Although animal models have been used to understand the aetiologies of polycystic ovary syndrome, these models are possibly not the best tool to study the underlying causes of this syndrome, as the disorder is uniquely human and does not occur naturally in animals. A recent study illustrates this point.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Pituitary P62 deficiency leads to female infertility by impairing luteinizing hormone production
Experimental & Molecular Medicine Open Access 27 August 2021
-
In rats with estradiol valerate-induced polycystic ovary syndrome, the acute blockade of ovarian β-adrenoreceptors improve ovulation
Reproductive Biology and Endocrinology Open Access 19 November 2019
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Azziz, R. et al. The polycystic ovary syndrome. Nat. Rev. Dis. Primers 2, 16057 (2016).
Abbott, D. H., Dumesic, D. A., Levine, J. E., Dunaif, A. & Padmanabhan, V. in Androgen Excess Disorders in Women 2nd edn Ch. 23 (eds Azziz, R., Nestler, J. E. & Dewailly, D.) 259–272 (Humana Press, 2006).
Caldwell, A. S. et al. Neuroendocrine androgen action is a key extraovarian mediator in the development of polycystic ovary syndrome. Proc. Natl Acad. Sci. USA 114, E3334–E3343 (2017).
Caldwell, A. S. et al. Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models. Endocrinology 155, 3146–3159 (2014).
De Leo, V., Lanzetta, D., D'Antona, D., la Marca, A. & Morgante, G. Hormonal effects of flutamide in young women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 83, 99–102 (1998).
Paradisi, R., Fabbri, R., Battaglia, C. & Venturoli, S. Ovulatory effects of flutamide in the polycystic ovary syndrome. Gynecol. Endocrinol. 29, 391–395 (2013).
Masahashi, T. et al. Spironolactone therapy for hyperandrogenic anovulatory women — clinical and endocrinological study. Nihon Sanka Fujinka Gakkai Zasshi 38, 95–101 (1986).
Siegberg, R., Ylöstalo, P., Laatikainen, T., Pelkonen, R. & Stenman, U. H. Endocrine and clinical effects of spironolactone in female hyperandrogenism. Arch. Gynecol. 240, 67–73 (1987).
Ibáñez, L. et al. Additive effects of insulin-sensitizing and anti-androgen treatment in young, nonobese women with hyperinsulinism, hyperandrogenism, dyslipidemia, and anovulation. J. Clin. Endocrinol. Metab. 87, 2870–2874 (2002).
Eagleson, C. A. et al. Polycystic ovarian syndrome: evidence that flutamide restores sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone. J. Clin. Endocrinol. Metab. 85, 4047–4052 (2000).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
R.A. serves as a consultant for Ansh Labs, Bayer Pharmaceuticals, Fractyl, Kindex Pharmaceuticals and Longitude Capital, and as an adviser to GlobalPET Imaging.
Rights and permissions
About this article
Cite this article
Azziz, R. Animal models for PCOS — not the real thing. Nat Rev Endocrinol 13, 382–384 (2017). https://doi.org/10.1038/nrendo.2017.57
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrendo.2017.57
This article is cited by
-
Pituitary P62 deficiency leads to female infertility by impairing luteinizing hormone production
Experimental & Molecular Medicine (2021)
-
In rats with estradiol valerate-induced polycystic ovary syndrome, the acute blockade of ovarian β-adrenoreceptors improve ovulation
Reproductive Biology and Endocrinology (2019)